FDA Approves Four Updated COVID-19 Vaccines for 2026-2027 Season as Cases Rise
The FDA approved four updated COVID-19 vaccines on September 7, 2026, ahead of the fall respiratory season. Independent medical groups also issued guidance recommending flu shots for everyone aged 6 months and older for the 2026-2027 season.
The Food and Drug Administration approved four updated COVID-19 vaccines on September 7, 2026, as case numbers rose heading into the fall respiratory season.
The updated vaccines are designed to address the strains circulating in 2026. Health officials are urging eligible Americans to get vaccinated before the fall surge.
Independent medical groups also issued guidance for the 2026-2027 respiratory season, recommending flu shots for everyone aged 6 months and older.
The dual push for COVID-19 and flu vaccination comes as public health officials work to reduce hospitalizations during the fall and winter months. Last year's respiratory season saw significant strain on hospital systems in several regions.
The FDA's approval of four separate COVID-19 vaccines gives providers and patients options from multiple manufacturers. Officials said the updated formulations are better matched to the variants currently spreading.
Health experts are encouraging people to schedule both their COVID-19 and flu shots at the same time to simplify the process. Studies have shown that getting both vaccines together is safe and does not reduce effectiveness.
People with weakened immune systems, adults over 65, and young children are considered at highest risk for severe illness and are being prioritized in outreach efforts.
The CDC is expected to issue formal recommendations for the updated vaccines in the coming days. Vaccines are available at pharmacies, doctor's offices, and community health centers nationwide.
